Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-02-07
2006-02-07
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S350000, C435S183000
Reexamination Certificate
active
06994988
ABSTRACT:
DNA isolates coding for tissue factor protein and methods of obtaining such DNA and producing tissue factor protein using recombinant expression systems for use in therapeutic composition for the treatment of coagulation disorders.
REFERENCES:
patent: 4727028 (1988-02-01), Santerre et al.
patent: 4742003 (1988-05-01), Derynck et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 5030576 (1991-07-01), Dull et al.
patent: 5110730 (1992-05-01), Edgington
patent: 5622931 (1997-04-01), Edgington et al.
patent: 36776 (1981-09-01), None
patent: 73657 (1983-09-01), None
patent: 139416 (1985-05-01), None
patent: 244221 (1987-11-01), None
patent: 278776 (1988-08-01), None
patent: WO84/01786 (1984-10-01), None
patent: WO 88/07543 (1988-10-01), None
patent: WO 88/09817 (1988-12-01), None
Edgington, T. et al “Molecular Cloning of Human Tissue factor dDNA”, Cell. vol 52, 639-640 Mar. 11, 1988.
Morrissey, Jones, et al “Molecular Cloning of the cDNA for Tissue Factor, the Cellular Receptor for the Initiation of the Coagulation Protease Cascade”, Cell, vol 50: 129-135 Jul. 1987.
Broze, G.J. et al.,J. Biol. Chem. 260(20):10917-10920 (1985).
Beck, ed.,Hematology, MIT Press, 381-382 & 436-437 (1981).
Berman, et al., “Engineering Glycoproteins For Use As Pharmaceuticals”,Trends in Biotechnology, 3(2):51-53 (1985).
Bjorklid, et al., “Purification And Some Properties Of The Protein Component Of Tissue Thromboplastin From Human Brain”,Biochem. J., 165:89-96 (1977).
Blakeslee, et al., “Scientists Find Long-Sought Key To How Blood Clots”, NY Times, (1987).
Boliyar, et al., Gene, 2:95 (1977).
Bom, V.J.J., et al., “Application Of Factor VII Sepharose Affinity Chromatography In The Purification Of Human Tissue Factor Apopratein”,Thrombosis Res., 42:635-643 (1986).
Bowie, et al., “Deciphering The Message In Protein Sequences: Tolerance To Amino Acid Substitutions”, Science, 247:1306-1310 (1990).
Broze, G.H., et al., “Purification Of Human Brain Tissue Factor”,J. Biol. Chem., 260(20):10917-10920 (1985).
Carlsen, E., et al., “Intravenous Injection Of Tissue Thromboplastin And Phospholipase C In Sheep”,Thromb. Haemostas., 43(3):315-319 (1982).
Carson, et al., “Tissue Factor Gene Localized To Human Chromosome 1 (1pter→1p21)”,Science, 229:991-993 (1985).
Carson, et al., “Plasma High Density Lipoproteins Inhibit The Activation Of Coagulation Factor X By Factor VIIa And Tissue Factor”,FEBS Letters, 132(1):37-40 (1981).
Carson, et al., “An Inhibitory Monoclonal Antibody Against Human Tissue Factor”, Blood, 70(2):490-493 (1987).
Carson, et al., “Monoclonal Antibodies Against Bovine Tissue Factor, Which Block Interaction With Factor VII”, Blood, 66(1):152-156 (1985).
Chang, et al., Nature, 275:615 (1978).
Creighton, “Proteins: Structure and Molecular Properties”, W.H. Freeman and Co., San Francisco, 79-86 (1983).
Cohen, F.N., et al.,Proc. Natl. Acad. Sci. USA, 69:2110 (1972).
Day, “How To Write And Publish A Scientific Ropes”, ISI Press, Philadelphia, PA, 15-19 (1983).
Dayloff, et al., “Cell Of Protein Sequence And Structure”, 5:89-99.
de Blainville, H., Gazette Medicale Paris, Series 2, 524 (1834).
de Boer, et al.,Proc. Natl. Acad. Sci. USA, 80:21-25 (1983).
Delente, J.S., “Glycosylation Revisited”,Trends In Biotechnology, 3(8):218 (1985).
Edge, et al., “Deglycosylation Of Glycoproteins By Trifluoromethanesulfonic Acid”,Analytical Bioch., 118:131-137 (1981).
Edgington, et al., “Molecular Cloning Of Human Tissue Factor cDNA”,Thrombosis And Haemostasis, 58(1):258 (1987).
Ewan, et al., “Production And Characterization Of A Monoclonal Antibody (A1-3) Binds Selectively To Activated Monocytes And Inhibits Monocyte Procoagulant Activity”,J. Immunol., 136(7):2408-2415 (1986).
Fedder, G., et al.,Thromb. Diath. Haemorrh., 27:365-376 (1972).
Fiers, et al.,Nature, 273:113 (1978).
Fisher, et al., “Cloning And Expression Of Human Tissue Factor cDNA”, Thrombosis Research, 48(1):89-99 (1987).
Freyssinet, J.M., et al., “Coextraction Of Thrombomodulin And Tissue Factor From Human Placenta: Effects Of Concanaval In A And Phospholipid Environment On Activity”,Thrombosis and Haemostasis, 55(1):112-118 (1986).
Giercksky, K.F., et al., “The Effect Of Intravenous Injection Of Purified Human Tissue Thomboplastin In Rats”, Scand. J.Haematol., 16:300-310 (1976).
Giles, A.R., et al., Blood. 60:727-730 (1982).
Glas, P. and Astrup, T., Am. J. Physiol., 219:1140-11476 (1970).
Goeddel, et al.,Nature, 281:544 (1979).
Goeddel, et al.,Nucleic Acids Res., 8:4057 (1980).
Gollub, et al., “Thromboplastinase—an Experimental Anti-thrombotic”, Thromb. Diath. Haemorh., 7:470-479 (1962).
Gonmori, H. and Takeda, Y.,J. Physiol., 229(3):618-626 (1975).
Gonmori, et al., “The Role Of Tissue Thromboplastin In The Development Of DIC Accompanying Neoplastic Diseases”,Biblio, Haemetol., 49:23-39 (1983).
Graham, F. and van der Fb. A.,Virology, 52:456-457 (1973).
Graham, F.L., et al.,J. Gen. Virol., 36:59 (1977).
Greenaway, P.J., et al.,Gene, 18:355-360 (1982).
Gubler, U. and Hoffman, B.J.,Gene, 25:263 (1983).
Guha, A., et al., “Affinity Purification Of Human Tissue Factor: Interaction Of Factor VII And Tissue Factor In Detergent Micelles”,Proc. Natl. Acad. Sci., 83:299-302 (1986).
Haemostasis, 13:150-155 (1983).
Hagen, et al., Proc. Natl. Acad. Sci. USA, 83:2412 (1986).
Hess, et al., J. Adv. Enzyme Reg., 7:149 (1968).
Hitzeman, et al., J. Biol. Chem., 255:2073 (1980).
Hood, et al.,Ann Rev. Immunol., 1:529 (1983).
Huynh, T, et al., DNA Cloning Techniques[ed. Grover, D.] (1984).
Hyatum, Y. and Prydz, H.,Thromb. Diath. Haemorrh., 21:217-222 (1969).
Itakura, et al., “Expression InEscherichia coliOf A Chemically Synthesized Gene For The Hormone Somatostatin”,Science, 198: 1056-1063 (1977).
Jaenicke, R., et al., “Folding Protein”,Protein Structure:A Practical Approach, Creighton, T.E., ed., IRL Press Oxford, England, ch. 9, 191-223 (1989).
Jones,Genetics, 85:12 (1977).
Jurss, et al., “Proteolysis-associated Deglycosylation Of Beta 1-adrenergic Receptor In Turkey Erthrocytes And Membranes”,Biochemistry, 24(13):3349-3354 (1985).
Kemp & Cowman, “Direct Immunoassay For DetectingEscherichia coliColonies That Contain Polypeptides Encoded By Cloned DNA Segments”,Proc. Natl. Acad. Sci., 78(7):4520-4524 (1981).
Kikutani, et al., “Molecular Structure Of Human Lymphocyte Receptor For Immunoglobulin E”,Cell, 47:657-665 (1986).
Kingsman, et al.,Gene, 7:141 (1979).
Kittler, J.M., et al., “Identification Of A cDNA Clone For Bovine Tissue Factor”, Federation Proceedings, 45(6):1639, Ab 927 (1986).
Kongisberg, et al., “Molecular Cloning Of The cDNA For Human Tissue Factor”,Cell, 52:639-640 (1988).
Kozak, M.,Nucl. Acids Res., 12:857 (1984).
Knuth et al., “Purification Of Proteins In The Denatured State”, Protein Purification: Micro To Macro: Alan R. Liss, Inc., 279-305.
Kurosawa, et al., “Urinary Procoagulant Behaves As Tissue Factor By Promoting Factor VIIa-Catalyzed Activation Of Factor X”,Thrombosis Res., 33:595-606 (1984).
Kyte and Doolittle,J. Mol. Biol., 157:105 (1982).
Laimins, L., et al.,Proc. Natl. Acad. Sci., 78:993 (1981).
Lawn, R., et al.,Nucleic Acids Res., 9:6103-6114 (1981).
Lewis, J. and Szato, I.F., “Effects Of Intravenous Tissue Thromboplastin In Dogs: Development Of An Anticoagulant”, J. Lab.Clin. Med., 60:261-273 (1962).
Light, H., “Protein Solubility, Protein Modifications And Protein Folding”, Biotechniques, 3(4):298-306 (1985).
Little, S., et al., “Functional Properties Of Carbohydrate-Depleted Tissue Plasminogen Activator”,Biochemistry, 23:6191 (1984).
Livnaht, et al., “Large Deletions In The Cytoplasmic Kinase
Lawn Richard M.
Vehar Gordon A.
Wion Karen L.
Carlson Karen Cochrane
Genetech, Inc.
Pabst Patent Group LLP
LandOfFree
Methods and deoxyribonucleic acid for the preparation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and deoxyribonucleic acid for the preparation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and deoxyribonucleic acid for the preparation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642068